Table 1. Summary of causative mutations identified after molecular analysis in the investigated cases.
Sample ID | Definitive Medical Diagnosis | Gene ID | NM Number | cDNA Level Change | Protein Level Change | NGS Coverage | HGMD* | MIM Number | Classification # |
---|---|---|---|---|---|---|---|---|---|
R6 | Spondylocarpotarsal Synostosis | FLNB | NM_001457.3 | c.1945C>T | p.(Arg649Ter) | 89X | CM040999 | 272460 | Pathogenic |
R34 | Neurofibromatosis-Noonan syndrome | NF1 | NM_000267.3 | c.625C>T | p.(Gln209Ter) | 139X | NA | 162200 | Pathogenic |
R43 | Geleophysic dysplasia 2 | FBN1 | NM_000138 | c.5284G>A | p.(Gly1762Ser) | 99X | CM115510 | 614185 | Pathogenic |
R47 | Ectrodactyly, Ectodermal Dysplasia, and Cleft Lip/Palate syndrome 3 | TP63 | NM_001114978.1 | c.740A>G | p.(His247Arg) | 133X | CM100075 | 604292 | Pathogenic |
R82 | Apert syndrome | FGFR2 | NM_022970.3 | c.755C>G | p.(Ser252Trp) | 86X | CM970526 | 101200 | Pathogenic |
R85 | Nail-patella syndrome | LMX1B | NM_001174146.1 | c.306C>G | p.(Tyr102Ter) | 35X | NA | 161200 | Likely Pathogenic |
R99 | Cleidocranial dysplasia | RUNX2 | NM_001015051.3 | c.476G>A | p.(Gly159Asp) | 125X | NA | 119600 | Likely Pathogenic |
R121 | Weaver syndrome | EZH2 | NM_152998.2 | c.149T>C | p.(Leu50Ser) | 194X | NA | 277590 | Likely Pathogenic |
R122 | Townes-Brock syndrome | SALL1 | NM_002968.2 | c.949C>T | p.(Pro317Ser) | 28X | NA | 107480 | Likely Pathogenic |
R150 | Hypochondroplasia | FGFR3 | NM_001163213.1 | c.1626C>G | p.(Asn542Lys) | 96X | CM950475 | 146000 | Pathogenic |
R156 | Wolcott-Rallison syndrome | EIF2AK3 | NM_004836.5 | c.1192C>T | p.(Gln398Ter) | 35X | CM113379 | 226980 | Pathogenic |
R163 | Spondyloepiphyseal Dysplasia, Congenital type | COL2A1 | NM_001844.4 | c.3301G>A | p.(Gly1101Arg) | 294X | NA | 183900 | Likely Pathogenic |
R174 | Trichrhinophalangeal syndrome I | TRPS1 | NM_014112.4 | c.1693C>T | p.(Gln565Ter) | 177X | NA | 190350 | Likely Pathogenic |
*HGMD Access code.
#Variant Classification according to the ACMG and AMP guidelines [78]. NA: Not applicable.